Format

Send to

Choose Destination
Prog Retin Eye Res. 2018 Nov;67:1-29. doi: 10.1016/j.preteyeres.2018.07.004. Epub 2018 Aug 1.

Artificial intelligence in retina.

Author information

1
Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria. Electronic address: ursula.schmidt-erfurth@meduniwien.ac.at.
2
Christian Doppler Laboratory for Ophthalmic Image Analysis, Vienna Reading Center, Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.

Abstract

Major advances in diagnostic technologies are offering unprecedented insight into the condition of the retina and beyond ocular disease. Digital images providing millions of morphological datasets can fast and non-invasively be analyzed in a comprehensive manner using artificial intelligence (AI). Methods based on machine learning (ML) and particularly deep learning (DL) are able to identify, localize and quantify pathological features in almost every macular and retinal disease. Convolutional neural networks thereby mimic the path of the human brain for object recognition through learning of pathological features from training sets, supervised ML, or even extrapolation from patterns recognized independently, unsupervised ML. The methods of AI-based retinal analyses are diverse and differ widely in their applicability, interpretability and reliability in different datasets and diseases. Fully automated AI-based systems have recently been approved for screening of diabetic retinopathy (DR). The overall potential of ML/DL includes screening, diagnostic grading as well as guidance of therapy with automated detection of disease activity, recurrences, quantification of therapeutic effects and identification of relevant targets for novel therapeutic approaches. Prediction and prognostic conclusions further expand the potential benefit of AI in retina which will enable personalized health care as well as large scale management and will empower the ophthalmologist to provide high quality diagnosis/therapy and successfully deal with the complexity of 21st century ophthalmology.

KEYWORDS:

Artificial intelligence (AI); Automated screening; Deep learning (DL); Machine learning (ML); Personalized healthcare (PHC); Prognosis and prediction

Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center